321 related articles for article (PubMed ID: 35566443)
1. Fertility after Curative Therapy for Sickle Cell Disease: A Comprehensive Review to Guide Care.
Nickel RS; Maher JY; Hsieh MH; Davis MF; Hsieh MM; Pecker LH
J Clin Med; 2022 Apr; 11(9):. PubMed ID: 35566443
[TBL] [Abstract][Full Text] [Related]
2. Fertility preservation for pediatric patients with hemoglobinopathies: Multidisciplinary counseling needed to optimize outcomes.
Bedrick BS; Kohn TP; Pecker LH; Christianson MS
Front Endocrinol (Lausanne); 2022; 13():985525. PubMed ID: 36353243
[TBL] [Abstract][Full Text] [Related]
3. Safety of Surgical Fertility Preservation Procedures in Children Prior to Hematopoietic Stem Cell Transplant.
Brodigan K; Kapadia M; Frazier AL; Laufer MR; Yu R; Weil BR; Ginsburg ES; Duncan C; Lehmann L
Transplant Cell Ther; 2021 Aug; 27(8):696.e1-696.e4. PubMed ID: 33864966
[TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up of boys who have undergone a testicular biopsy for fertility preservation.
Kanbar M; de Michele F; Giudice MG; Desmet L; Poels J; Wyns C
Hum Reprod; 2021 Jan; 36(1):26-39. PubMed ID: 33259629
[TBL] [Abstract][Full Text] [Related]
5. Female Reproductive Health Outcomes after Hematopoietic Cell Transplantation for Sickle Cell Disease: Is Reduced Intensity Better Than Myeloablative Conditioning?
Meacham LR; George S; Veludhandi A; Pruett MC; Haight AE; Arnold SD; Elchuri S; Stenger E; Krishnamurti L
Transplant Cell Ther; 2023 Aug; 29(8):531.e1-531.e4. PubMed ID: 37169288
[TBL] [Abstract][Full Text] [Related]
6. Fertility preservation in children and adolescents with cancer.
Levine J
Minerva Pediatr; 2011 Feb; 63(1):49-59. PubMed ID: 21311429
[TBL] [Abstract][Full Text] [Related]
7. Update on fertility preservation from the Barcelona International Society for Fertility Preservation-ESHRE-ASRM 2015 expert meeting: indications, results and future perspectives.
Martinez F;
Fertil Steril; 2017 Sep; 108(3):407-415.e11. PubMed ID: 28739117
[TBL] [Abstract][Full Text] [Related]
8. Curative therapies: Allogeneic hematopoietic cell transplantation from matched related donors using myeloablative, reduced intensity, and nonmyeloablative conditioning in sickle cell disease.
Guilcher GMT; Truong TH; Saraf SL; Joseph JJ; Rondelli D; Hsieh MM
Semin Hematol; 2018 Apr; 55(2):87-93. PubMed ID: 29958564
[TBL] [Abstract][Full Text] [Related]
9. Update on fertility preservation from the Barcelona International Society for Fertility Preservation-ESHRE-ASRM 2015 expert meeting: indications, results and future perspectives.
Martinez F
Hum Reprod; 2017 Sep; 32(9):1802-1811. PubMed ID: 29117320
[TBL] [Abstract][Full Text] [Related]
10. Fertility challenges for women with sickle cell disease.
Ghafuri DL; Stimpson SJ; Day ME; James A; DeBaun MR; Sharma D
Expert Rev Hematol; 2017 Oct; 10(10):891-901. PubMed ID: 28891355
[TBL] [Abstract][Full Text] [Related]
11. Bone Marrow Transplantation after Nonmyeloablative Treosulfan Conditioning Is Curative in a Murine Model of Sickle Cell Disease.
Devadasan D; Sun CW; Westin ER; Wu LC; Pawlik KM; Townes TM; Goldman FD
Biol Blood Marrow Transplant; 2018 Aug; 24(8):1554-1562. PubMed ID: 29684562
[TBL] [Abstract][Full Text] [Related]
12. Safety and usefulness of cryopreservation of ovarian tissue to preserve fertility: a 12-year retrospective analysis.
Imbert R; Moffa F; Tsepelidis S; Simon P; Delbaere A; Devreker F; Dechene J; Ferster A; Veys I; Fastrez M; Englert Y; Demeestere I
Hum Reprod; 2014 Sep; 29(9):1931-40. PubMed ID: 24958067
[TBL] [Abstract][Full Text] [Related]
13. Ovarian tissue cryopreservation for fertility preservation before hematopoietic stem cell transplantation in patients with sickle cell disease: safety, ovarian function follow-up, and results of ovarian tissue transplantation.
Missontsa MM; Bernaudin F; Fortin A; Dhédin N; Pondarré C; Yakouben K; Neven B; Castelle M; Cavazzana M; Lezeau H; Peycelon M; Paye-Jaouen A; Sroussi J; Diesch-Furlanetto T; Barraud-Lange V; Sarnacki S; Fahd M; Marchand I; Delcour C; Vexiau D; Arlet JB; Kamdem A; Arnaud C; Dalle JH; Poirot C
J Assist Reprod Genet; 2024 Apr; 41(4):1027-1034. PubMed ID: 38358434
[TBL] [Abstract][Full Text] [Related]
14. Sexuality- and Fertility-Related Issues in Women after Allogeneic Hematopoietic Stem Cell Transplantation.
Forgeard N; Jestin M; Vexiau D; Chevillon F; Ricadat E; Peffault de Latour R; Robin M; Sicre de Fontbrune F; Xhaard A; Michonneau D; Boissel N; Poirot C; Dhédin N
Transplant Cell Ther; 2021 May; 27(5):432.e1-432.e6. PubMed ID: 33789835
[TBL] [Abstract][Full Text] [Related]
15. Testicular Tissue Banking for Fertility Preservation in Young Boys: Which Patients Should Be Included?
Delgouffe E; Braye A; Goossens E
Front Endocrinol (Lausanne); 2022; 13():854186. PubMed ID: 35360062
[TBL] [Abstract][Full Text] [Related]
16. Risks associated with fertility preservation for women with sickle cell anemia.
Pecker LH; Maher JY; Law JY; Beach MC; Lanzkron S; Christianson MS
Fertil Steril; 2018 Sep; 110(4):720-731. PubMed ID: 30196969
[TBL] [Abstract][Full Text] [Related]
17. Childhood cancer and hematological disorders negatively affect spermatogonial quantity at diagnosis: a retrospective study of a male fertility preservation cohort.
Masliukaite I; Ntemou E; Feijen EAM; van de Wetering M; Meissner A; Soufan AT; Repping S; Kremer LMC; Jahnukainen K; Goossens E; van Pelt AMM
Hum Reprod; 2023 Mar; 38(3):359-370. PubMed ID: 36708005
[TBL] [Abstract][Full Text] [Related]
18. Across the Myeloablative Spectrum: Hematopoietic Cell Transplant Conditioning Regimens for Pediatric Patients with Sickle Cell Disease.
Limerick E; Abraham A
J Clin Med; 2022 Jul; 11(13):. PubMed ID: 35807140
[TBL] [Abstract][Full Text] [Related]
19. Spermatogonial quantity in human prepubertal testicular tissue collected for fertility preservation prior to potentially sterilizing therapy.
Stukenborg JB; Alves-Lopes JP; Kurek M; Albalushi H; Reda A; Keros V; Töhönen V; Bjarnason R; Romerius P; Sundin M; Norén Nyström U; Langenskiöld C; Vogt H; Henningsohn L; Mitchell RT; Söder O; Petersen C; Jahnukainen K
Hum Reprod; 2018 Sep; 33(9):1677-1683. PubMed ID: 30052981
[TBL] [Abstract][Full Text] [Related]
20. Reduced-Intensity Conditioning Mitigates Risk for Primary Ovarian Insufficiency but Does Not Decrease Risk for Infertility in Pediatric and Young Adult Survivors of Hematopoietic Stem Cell Transplantation.
Bender JD; Oquendo-Del Toro H; Benoit J; Howell JC; Badia P; Davies SM; Grimley MS; Jodele S; Phillips C; Burns K; Marsh R; Nelson A; Wallace G; Dandoy CE; Pate A; Strine AC; Frias O; Breech L; Rose SR; Hoefgen H; Khandelwal P; Myers KC
Transplant Cell Ther; 2023 Feb; 29(2):130.e1-130.e8. PubMed ID: 36323400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
